Stocks Comparison
Onto Innovation vs Thermo Fisher Scientific: revenue, profit, margins and growth compared
Onto Innovation brought in $1B of revenue in fiscal 2024, Thermo Fisher Scientific $44.6B in fiscal 2025. Revenue changed by +1.8% at Onto Innovation and +3.9% at Thermo Fisher Scientific on the year before, so Thermo Fisher Scientific grew faster. Onto Innovation kept 13.6% of its revenue as net profit, Thermo Fisher Scientific 15.0%. Free cash flow was $299.8M at Onto Innovation and $6.3B at Thermo Fisher Scientific.
Side by side, latest fiscal year
| ONTO | TMO | |
|---|---|---|
| Fiscal year ended | FY2024 (January 3, 2026) | FY2025 (December 31, 2025) |
| Revenue | $1B | $44.6B |
| Revenue growth | +1.8% | +3.9% |
| Net income | $136.8M | $6.7B |
| Net margin | 13.6% | 15.0% |
| Free cash flow | $299.8M | $6.3B |
| Free cash flow margin | 29.8% | 14.1% |
| Earnings per share (diluted) | $2.78 | $17.74 |
| Cash | $346.1M | $9.9B |
| Debt | n/a | $39.2B |
| Price to earnings | 103.5 | 38.0 |
| Market value | $14.1B | $249.6B |
| Dividend yield | n/a | 0.25% |
| Rank by revenue in sector | #271 of 451 · Industrials | #12 of 451 · Industrials |
Over the years
Questions about Onto Innovation and Thermo Fisher Scientific
Which is bigger by revenue, Onto Innovation or Thermo Fisher Scientific?
Thermo Fisher Scientific is bigger by revenue: $44.6B in fiscal 2025, against $1B for Onto Innovation in fiscal 2024.
Which keeps more of its revenue as profit, Onto Innovation or Thermo Fisher Scientific?
Onto Innovation had a net margin of 13.6% in fiscal 2024; Thermo Fisher Scientific had 15.0% in fiscal 2025.
Which grew revenue faster, Onto Innovation or Thermo Fisher Scientific?
In their latest fiscal years revenue changed by +1.8% at Onto Innovation and +3.9% at Thermo Fisher Scientific.
Where do these numbers come from?
From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.